SKAN Group AG
SIX:SKAN

Watchlist Manager
SKAN Group AG Logo
SKAN Group AG
SIX:SKAN
Watchlist
Price: 74 CHF -0.8%
Market Cap: 1.7B CHF
Have any thoughts about
SKAN Group AG?
Write Note

SKAN Group AG
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SKAN Group AG
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
SKAN Group AG
SIX:SKAN
Other Long-Term Assets
CHf1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Other Long-Term Assets
CHf14.9m
CAGR 3-Years
39%
CAGR 5-Years
22%
CAGR 10-Years
17%
Siegfried Holding AG
SIX:SFZN
Other Long-Term Assets
CHf33.3m
CAGR 3-Years
-13%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Other Long-Term Assets
CHf290m
CAGR 3-Years
-69%
CAGR 5-Years
-51%
CAGR 10-Years
-24%
Tecan Group AG
SIX:TECN
Other Long-Term Assets
CHf46.9m
CAGR 3-Years
14%
CAGR 5-Years
18%
CAGR 10-Years
N/A
PolyPeptide Group AG
SIX:PPGN
Other Long-Term Assets
€16.7m
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
N/A
No Stocks Found

SKAN Group AG
Glance View

Market Cap
1.7B CHF
Industry
Life Sciences Tools & Services

SKAN Group AG engages in the development, design, and manufacture of process isolators for the aseptic filling of biopharmaceutical products. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2007-04-05. The company concentrates on companies from the industry, micro and medical technology, processing and material technology, information technology and related services. Target enterprises are those being in special situations, such as management buy-out and buy-in, changes in shareholders’ structure, succession financing, as well as coming through growth or expansion phase. The firm acts as an entrepreneurial partner in the long term. Operational activities are delegated to the independent advisor BV Partners AG. BV Holding AG and BV Partners AG form the BVgroup. As of December 31, 2011, its investment portfolio included nine companies: Covalys BioSciences AG, E2E Technologies Ltd., Lonstroff Holding AG, Piexon AG, POLYDATA AG, SKAN Holding AG, Sphinx Werkzeuge AG, Ypsomed Holding AG and Ziemer Group AG.

SKAN Intrinsic Value
93.59 CHF
Undervaluation 21%
Intrinsic Value
Price

See Also

What is SKAN Group AG's Other Long-Term Assets?
Other Long-Term Assets
1m CHF

Based on the financial report for Dec 31, 2023, SKAN Group AG's Other Long-Term Assets amounts to 1m CHF.

What is SKAN Group AG's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 1Y
19%

Over the last year, the Other Long-Term Assets growth was 19%.

Back to Top